Bromodomain inhibitors are potent epigenetic regulators of catabolic gene expression in human osteoarthritic chondrocytes. (April 2018) - de Andrés, M.C.; Madhusudan, N.; Bountra, C.; Oppermann, U.; Oreffo, R.O.